Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172561 | SCV000051404 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000037485 | SCV000061143 | benign | not specified | 2015-05-20 | criteria provided, single submitter | clinical testing | p.Glu1295Gln in exon 28 of MYH6: This variant is not expected to have clinical s ignificance because it has been identified in 1.7% (151/8650) of East Asian chro mosomes, including 1 homozygote, by the Exome Aggregation Consortium (ExAC, http ://exac.broadinstitute.org; dbSNP rs34935550). |
Ambry Genetics | RCV000253033 | SCV000317520 | benign | Cardiovascular phenotype | 2015-10-27 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000037485 | SCV000527969 | benign | not specified | 2016-11-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001086651 | SCV000557886 | benign | Hypertrophic cardiomyopathy 14 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000172561 | SCV000610331 | likely benign | not provided | 2017-05-30 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000037485 | SCV000740614 | likely benign | not specified | 2016-08-31 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769410 | SCV000900803 | benign | Cardiomyopathy | 2017-04-21 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852695 | SCV000995406 | benign | Restrictive cardiomyopathy; Hypertrophic cardiomyopathy | 2019-01-31 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000172561 | SCV001474494 | benign | not provided | 2023-09-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000172561 | SCV005074449 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | MYH6: BS1, BS2 |
Diagnostic Laboratory, |
RCV000172561 | SCV001743493 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000037485 | SCV001918756 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000037485 | SCV001932848 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000037485 | SCV001954960 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000037485 | SCV001967925 | benign | not specified | no assertion criteria provided | clinical testing |